butyrate glp-1 generated by gut microbiota and its therapeutic role in metabolic syndrome Could Your Gut Hold the

ASK-1, apoptosis signaling kinase-1

peripheral atherosclerotic disease) who cannot be diagnosed with FH according to the Dutch criteria, although they have lipid disorders and do not achieve their LDL-C targets, according to the adopted guidelines (), and in whom all other standard therapies have failed (for at least 3 months) or are poorly tolerated, and/or there are contraindications to pharmacological treatment (adverse effects, complications, e.g

Specific vitamin deficiencies can particularly manifest as parkinsonism features

(See the blog.) A systematic review found that these drugs might be helpful in intracranial hypertension, a condition that appears to be widespread in these diseases